Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of verapamil on platelet aggregation.

E Glusa1

  • 1Institute of Pharmacology and Toxicology, Medical Academy Erfurt, GDR.

Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1988
PubMed
Summary

Verapamil, a calcium channel blocker, effectively inhibits 5-HT-potentiated platelet aggregation. It works non-competitively against serotonin, showing greater efficacy than diltiazem.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteinase-activated receptor agonists stimulate the increase in intracellular Ca2+ in cardiomyocytes and proliferation of cardiac fibroblasts from chick embryos.

Bulletin of experimental biology and medicine·2008
Same author

[Effect of thrombin on survival of hippocampal neurons].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova·2005
Same author

Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs.

Naunyn-Schmiedeberg's archives of pharmacology·2005
Same author

Immobilized thrombin receptor agonist peptide accelerates wound healing in mice.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2001
Same author

Endothelium-dependent relaxation induced by cathepsin G in porcine pulmonary arteries.

British journal of pharmacology·2001
Same author

Systemic vascular effects of thrombin and thrombin receptor activating peptide in rats.

Thrombosis research·2001

Area of Science:

  • Pharmacology
  • Cardiovascular Research
  • Hematology

Background:

  • Platelet aggregation plays a crucial role in thrombosis and hemostasis.
  • Calcium channel blockers are widely used for cardiovascular conditions.
  • Serotonin (5-HT) is a key mediator in platelet activation.

Purpose of the Study:

  • To investigate the in vitro effects of verapamil on human platelet aggregation.
  • To compare verapamil's anti-platelet activity with diltiazem and cyproheptadine.
  • To elucidate the mechanism of verapamil's interaction with 5-HT-induced aggregation.

Main Methods:

  • In vitro study of human blood platelet aggregation.
  • Comparative analysis using verapamil, diltiazem, and cyproheptadine.
  • Assessment of aggregation induced by various agonists (5-HT, ADP, adrenaline, collagen).

Main Results:

  • Verapamil demonstrated significant inhibition of 5-HT-potentiated ADP-induced platelet aggregation.
  • Verapamil's inhibitory effect was more pronounced on 5-HT-potentiated aggregation compared to adrenaline, ADP, or collagen-induced aggregation.
  • Verapamil antagonized the 5-HT effect in a non-competitive manner; cyproheptadine was more potent.
  • Diltiazem showed considerably less efficacy than verapamil.

Conclusions:

  • Verapamil is an effective inhibitor of 5-HT-mediated platelet aggregation.
  • The non-competitive antagonism of the 5-HT effect suggests a specific interaction pathway.
  • Verapamil's anti-platelet properties warrant further investigation for potential therapeutic applications in thrombotic disorders.

Related Experiment Videos